{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:12:50Z","timestamp":1789726370303,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijid.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:58:32Z","timestamp":1557745112000},"page":"127-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Bone penetration of daptomycin in diabetic patients with bacterial foot infections"],"prefix":"10.1016","volume":"85","author":[{"given":"Antoine","family":"Grillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Argemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannot","family":"Gaudias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ronde-Ousteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Jenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Jehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijid.2019.05.011_bib0005","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1128\/AAC.49.12.5024-5032.2005","article-title":"In vitro activity of linezolid against key gram-positive organisms isolated in the United States: results of the LEADER 2004 surveillance program","volume":"49","author":"Draghi","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2019.05.011_bib0010","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1981.03320140063033","article-title":"The inhibitory quotient: a method for interpreting minimum inhibitory concentration data","volume":"246","author":"Ellner","year":"1981","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2019.05.011_bib0015","volume":"vol. 9.0","author":"EUCAST","year":"2019"},{"key":"10.1016\/j.ijid.2019.05.011_bib0020","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10096-009-0764-y","article-title":"In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies","volume":"28","author":"Gallon","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2019.05.011_bib0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","article-title":"Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia","volume":"47","author":"Garazzino","year":"2008","journal-title":"Clin Pharmacokinet"},{"issue":"April (2)","key":"10.1016\/j.ijid.2019.05.011_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/17453674.2014.966290","article-title":"The role of microbial biofilms in prosthetic joint infections","volume":"86","author":"Gbejuade","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.ijid.2019.05.011_bib0035","first-page":"47","article-title":"Daptomycin: an evidence-based review of its role in the treatment of gram-positive infections. Vol. 9","author":"Gonzalez-Ruiz","year":"2016","journal-title":"Infect Drug Resist"},{"issue":"November (44)","key":"10.1016\/j.ijid.2019.05.011_bib0040","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European As","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"September (Suppl. 1)","key":"10.1016\/j.ijid.2019.05.011_bib0045","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections","volume":"69","author":"Jacqueline","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2019.05.011_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diagmicrobio.2017.03.003","article-title":"Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations","volume":"88","author":"Jones","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2019.05.011_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijid.2019.05.011_bib0060","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.05745-11","article-title":"Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics","volume":"56","author":"Lef\u00e8vre","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2019.05.011_bib0065","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.05.011_bib0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkh531","article-title":"Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections","volume":"55","author":"Lipsky","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"February (3)","key":"10.1016\/j.ijid.2019.05.011_bib0075","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.ijid.2019.05.011_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-015-2515-6","article-title":"Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry","volume":"35","author":"Malizos","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijid.2019.05.011_bib0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/dmrr.2740","article-title":"The diabetic foot in 2015: an overview","volume":"32","author":"Markakis","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"July (7)","key":"10.1016\/j.ijid.2019.05.011_bib0090","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.02344-14","article-title":"Penetration of daptomycin into bone and synovial fluid in joint replacement","volume":"58","author":"Montange","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"March","key":"10.1016\/j.ijid.2019.05.011_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-016-0130-8","article-title":"Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE","volume":"15","author":"Seaton","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"January (1)","key":"10.1016\/j.ijid.2019.05.011_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2015.11.005","article-title":"Towards a definition of daptomycin optimal dose: lessons learned from experimental and clinical data","volume":"47","author":"Senneville","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"June (6)","key":"10.1016\/j.ijid.2019.05.011_bib0105","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/jac\/dkq109","article-title":"Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections","volume":"65","author":"Traunm\u00fcller","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2019.05.011_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijantimicag.2010.03.007","article-title":"Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections","volume":"36","author":"Traunm\u00fcller","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.05.011_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijid.2015.09.023","article-title":"Diabetic foot infections: what have we learned in the last 30 years?","volume":"40","author":"U\u00e7kay","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"Suppl. 7","key":"10.1016\/j.ijid.2019.05.011_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1469-0691.2001.00059.x","article-title":"Limitations of presently available glycopeptides in the treatment of Gram-positive infection","volume":"7","author":"Ziglam","year":"2001","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219302176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:45:40Z","timestamp":1761119140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219302176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":24,"alternative-id":["S1201971219302176"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.05.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone penetration of daptomycin in diabetic patients with bacterial foot infections","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}